We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,502 results
  1. Is unicentric familial papillary thyroid microcarcinoma different from multicentric?

    Background

    Familial papillary thyroid microcarcinoma (FPTMC) appears to be more aggressive than sporadic papillary thyroid microcarcinoma (SPTMC)....

    A. Ríos, J. Ruiz-Pardo, ... J. M. Rodríguez in Endocrine
    Article 25 July 2023
  2. Medullary Thyroid Carcinoma: A Single Institute Experience

    Medullary thyroid carcinoma is a rare tumour that is anatomically located in the thyroid gland but is functionally a neuroendocrine tumour. It is...

    Sonal Trivedi, T. Salahuddin, ... Shivam Pandya in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 22 May 2023
  3. Current Surveillance and Treatment Guidelines for Thyroid Carcinoma

    Purpose of Review

    Although thyroid nodules are often a common finding during examination of the thyroid gland, with a prevalence of approximately 5%...

    Kirsten Lung, Isheeta Madeka, Alliric I. Willis in Current Surgery Reports
    Article Open access 05 July 2024
  4. Unforeseen Complication in a Patient with Recurrent Papillary Carcinoma Thyroid

    The incidence of thyroid papillary cancer is approximately 13.5 per 100,000.Papillary thyroid carcinoma (PTC) is usually associated with favorable...

    L. Somu, Thirunavukarasu, ... Malavika P in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 14 June 2024
  5. Cribriform Morular Thyroid Carcinoma – Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case

    A 44-year-old female patient with a familial adenomatous polyposis (FAP) was diagnosed with a cribriform morular thyroid carcinoma (CMTC). We...

    Matthias S. Dettmer, Sandra Hürlimann, ... Corinna Wicke in Endocrine Pathology
    Article Open access 30 May 2023
  6. Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience

    Background

    The purpose of the article was to evaluate the existence of significant clinical, pathological and prognostic differences between familial...

    Claudio Spinelli, Irene Piccolotti, ... Silvia Strambi in World Journal of Surgery
    Article Open access 23 April 2021
  7. Poorly differentiated papillary thyroid carcinoma in a 5-year-old girl: a case report

    Background

    The incidence of thyroid cancer has been increasing among the population less than 20 years of age, especially during the second decade of...

    Mohanned Mohsen, Omar Hamdy, ... Mohamed Ezat in Egyptian Pediatric Association Gazette
    Article Open access 26 February 2024
  8. HRAS-mutated primary thyroid malignant melanoma or medullary thyroid carcinoma with melanocytic dedifferentiation? A singular case with an ontogeny–phylogeny quandary

    Melanotic pigment in the thyroid is practically synonymous with chronic minocycline therapy and rare cases of melanotic medullary thyroid carcinoma....

    Priyadarsani Subramanian, Anuja Deshmukh, ... Neha Mittal in Virchows Archiv
    Article 07 August 2023
  9. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study

    Purpose

    Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few...

    A. Ríos, M. A. Rodríguez, ... J. M. Rodríguez in Langenbeck's Archives of Surgery
    Article Open access 17 October 2022
  10. Distant Metastasis as the First Presentation of Thyroid Carcinoma

    Introduction

    Thyroid carcinoma is the most common endocrine cancer which may manifest with unusual presentations. We addressed distant metastases as...

    Mohammad Talebpour, Hossein Zabihi Mahmoudabadi, ... Maryam Bahreini in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 08 December 2022
  11. De novo familial adenomatous polyposis associated thyroid cancer with a c.2929delG frameshift deletion mutation in APC: a case report and literature review

    Background

    Germline mutations in the APC gene located on chromosome 5q 21–22 can lead to familial adenomatous polyposis (FAP) and the development of...

    Miaorong Xu, Yuyan Zheng, ... Da Wang in World Journal of Surgical Oncology
    Article Open access 02 March 2023
  12. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)

    Cribriform morular thyroid carcinoma (CMTC) is a rare malignant thyroid tumor with a peculiar growth pattern secondary to permanent activation of the...

    Ana Echegoyen-Silanes, José Javier Pineda-Arribas, ... José Manuel Cameselle-Teijeiro in Virchows Archiv
    Article Open access 23 January 2023
  13. International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience

    Introduction

    Medullary carcinoma (MTC) is a rare neuroendocrine thyroid neoplasm. The international medullary thyroid carcinoma grading scheme...

    Varnika Rai, Anurag Saha, ... Poornima Manimaran in European Archives of Oto-Rhino-Laryngology
    Article 27 November 2023
  14. High Fatty Acid-Binding Protein 4 Expression Associated with Favorable Clinical Characteristics and Prognosis in Papillary Thyroid Carcinoma

    Fatty acid-binding protein 4 ( FABP4 ), a fatty acid transporter that coordinates lipid metabolism, is reported to exert a tumorigenic role in certain...

    Chao-Wen Cheng, Wen-Fang Fang, ... Jiunn-Diann Lin in Endocrine Pathology
    Article 17 June 2024
  15. Wnt/β-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma

    Background

    Anaplastic thyroid carcinoma (ATC) is a highly aggressive malignancy that has consistently shown Wnt/β-catenin (canonical) signaling...

    Diana Diaz, Kensey Bergdorf, ... Vivian L. Weiss in Endocrine
    Article Open access 28 May 2024
  16. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma

    Background

    To date, although most thyroid carcinoma (THCA) achieves an excellent prognosis, some patients experience a rapid progression episode, even...

    Yongsheng Huang, Peiliang Lin, ... **aoming Huang in BMC Endocrine Disorders
    Article Open access 11 May 2024
  17. A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma

    Papillary thyroid carcinoma (PTC) is the most common thyroid cancer, posing a growing clinical challenge. PTC exhibits two age-related peaks, with...

    Tahereh Haghzad, Babak Khorsand, ... Mehdi Hedayati in Endocrine
    Article 17 June 2024
  18. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma

    Medullary thyroid carcinoma (MTC) is a C-cell-derived epithelial neuroendocrine neoplasm. With the exception of rare examples, most are...

    Chan Kwon Jung, Shipra Agarwal, ... Ozgur Mete in Endocrine Pathology
    Article 08 March 2023
  19. Outcome and complications after surgery for thyroid carcinoma in pediatric age—an evaluation of practice

    Objectives

    To discuss management protocol, surgical complications, and outcomes of thyroid carcinoma in children.

    Methods

    We performed a retrospective...

    Ahmed Elgendy, Emad M. Shehata, Sherif M. Shehata in World Journal of Surgical Oncology
    Article Open access 14 September 2022
  20. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations

    Our understanding of the genomics and epigenomics of medullary thyroid carcinoma (MTC) has advanced since the initial recognition of RET as a driver...

    Justine A. Barletta, Vânia Nosé, Peter M. Sadow in Endocrine Pathology
    Article 25 January 2021
Did you find what you were looking for? Share feedback.